EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Using Omics to Identify Novel Therapeutic Targets in Heart Failure

Christelle Lteif iD, Yimei Huang iD, Leonardo A Guerra iD, Brian E Gawronski iD, Julio D Duarte iD

Circulation: Genomic and Precision Medicine · 2024-06 · 17 (3)

DOI: 10.1161/circgen.123.004398 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024-06. Verfasst von Christelle Lteif und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacogenomics and Precision Medicine, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharma…. Hauptthemen laut MEDLINE: Heart Failure, Metabolomics, Proteomics, Genomics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omics refers to the measurement and analysis of the totality of molecules or biological processes involved within an organism. Examples of omics data include genomics, transcriptomics, epigenomics, proteomics, metabolomics, and more. In this review, we present the available literature reporting omics data on heart failure that can inform the development of novel treatments or innovative treatment strategies for this disease. This includes polygenic risk scores to improve prediction of genomic data and the potential of multiomics to more efficiently identify potential treatment targets for further study. We also discuss the limitations of omic analyses and the barriers that must be overcome to maximize the utility of these types of studies. Finally, we address the current state of the field and future opportunities for using multiomics to better personalize heart failure treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMetabolomicsProteomicsGenomicsEpigenomicsHumansPrecision Medicine

Stichwörter der Autor:innen

drug discoverygenomicsheart failuremultiomicspolygenic risk scoretherapeuticstranscriptomics

Autor:innen und Institutionen

  • Center for Pharmacogenomics and Precision Medicine, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL.

ORCID-Profile: Christelle Lteif, Yimei Huang, Leonardo A Guerra, Brian E Gawronski, Julio D Duarte

Förderung

  • NHGRI NIH HHS

Zitieren

APA

Lteif, C., Huang, Y., Guerra, L. A., Gawronski, B. E., & Duarte, J. D. (2024). Using Omics to Identify Novel Therapeutic Targets in Heart Failure. Circulation: Genomic and Precision Medicine, 17(3). https://doi.org/10.1161/circgen.123.004398

Vancouver

Lteif C, Huang Y, Guerra LA, Gawronski BE, Duarte JD. Using Omics to Identify Novel Therapeutic Targets in Heart Failure. Circulation: Genomic and Precision Medicine. 2024;17(3). doi:10.1161/circgen.123.004398

BibTeX
@article{Lteif2024,
  author = {Lteif, Christelle and Huang, Yimei and Guerra, Leonardo A and Gawronski, Brian E and Duarte, Julio D},
  title = {Using Omics to Identify Novel Therapeutic Targets in Heart Failure},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2024},
  volume = {17},
  number = {3},
  doi = {10.1161/circgen.123.004398}
}
Kostenlos starten →